IMT Outcomes in Sufferers of Severe Walking Disabilities and Intensive Care Unit Acquired Weakness

Launched by CAIRO UNIVERSITY · Jan 8, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on understanding the outcomes of a specific treatment for patients suffering from severe walking disabilities caused by a condition known as Intensive Care Unit-acquired Weakness (ICU-acquired weakness). This condition can affect up to 30% of patients who have been critically ill and in intensive care, making it difficult for them to walk and perform daily activities. The trial is currently recruiting participants aged 23 to 27, and it is open to all genders. To be eligible, participants must have been diagnosed with ICU-acquired weakness and show significant walking difficulties through a specific walking test. However, individuals with lower limb amputations or certain orthopedic or spinal issues cannot participate.

If you or a loved one qualifies for this trial, you can expect to be involved in a study that aims to improve understanding and treatment for those facing challenges in mobility after a serious illness. Being part of this trial could contribute to better care for future patients with similar conditions. It's important to note that the findings could help develop new approaches to support recovery for those affected by ICU-acquired weakness.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • sufferers with intensive care unit acquired weakness
• • Older sufferers patients with severe walking disability detected by Modified Functional Ambulation Category test,
• Exclusion Criteria:
• • lower limb amputations
• • orthopedic or spinal disc disorders